Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | -7.82% | -20.83% | -27.54% |
Mar. 27 | Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024 | |
Mar. 27 | GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 28.74M | Capitalization | 110M |
---|---|---|---|---|---|
Net income 2024 * | -40M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.83 x |
P/E ratio 2024 * |
-2.91
x | P/E ratio 2025 * |
-4.99
x | Employees | 35 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
Latest transcript on GlycoMimetics, Inc.
1 day | -7.82% | ||
1 week | -20.83% | ||
Current month | -43.00% | ||
1 month | -39.36% | ||
3 months | -45.89% | ||
6 months | +51.33% | ||
Current year | -27.54% |
Managers | Title | Age | Since |
---|---|---|---|
Harout Semerjian
CEO | Chief Executive Officer | 52 | 21-08-05 |
Rachel King
FOU | Founder | 64 | 03-04-03 |
Brian Hahn
DFI | Director of Finance/CFO | 49 | 10-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 16-03-16 |
Patricia Andrews
BRD | Director/Board Member | 66 | 17-06-11 |
Scott Jackson
BRD | Director/Board Member | 60 | 18-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.71 | -7.82% | 547,997 |
24-04-24 | 1.855 | +1.09% | 664,799 |
24-04-23 | 1.835 | +1.94% | 1,231,604 |
24-04-22 | 1.8 | -6.49% | 1,477,807 |
24-04-19 | 1.925 | -10.88% | 1,169,156 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.54% | 110M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.41% | 22.02B | |
-17.84% | 20.9B | |
-8.77% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- GLYC Stock